02676nam 2200517 450 991013844970332120221022134619.0953-51-6571-2(CKB)3230000000075894(NjHacI)993230000000075894(oapen)https://directory.doabooks.org/handle/20.500.12854/65300(OCoLC)57178158ocm57178158(OCoLC)993230000000075894(EXLCZ)99323000000007589420221022d2011 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierDiabetes insipidus /edited by Kyuzi KamoiIntechOpen2011Rijeka, Croatia :InTech,[2011]©20111 online resource (150 pages)NIH publication ;no. 03-4620Title from title screen (viewed on Dec. 1, 2004).Caption title."June 2003."953-307-367-5 The first chapter of the book reports on the management of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus and its associated endocrinological/neurological sequelae in the national survey. The next chapter addresses DI and head injuries. Next, the management of neuroendocrine instability during maintenance of potential organ donors is described. Organ transplants have gradually increased worldwide. To have maintenance of appropriate potential organs, AVP is needed. Furthermore, nephrogenic DI-the potential therapeutic drugs and analysis of membrane protein stability is the topic of the next two chapters, followed by new insights into the diagnosis and management of pregnancy-related DI. The seventh chapter reports on the problems with differential diagnosis in a case of central DI in a female patient with bipolar disorder. The lithium treatment usually resulted in nephrogenic DI. Finally, over the last years, the development of MRI imaging on the pituitary gland with the stalk and hypothalamus has advanced. The final chapter interprets imaging techniques in DI in detail.DiabetesEndocrinologyDiabetes.616.462Kamoi Kyuziedt1385300Kamoi KyuziNational Kidney and Urologic Diseases Information Clearinghouse (U.S.)National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)NjHacINjHaclBOOK9910138449703321Diabetes insipidus3432624UNINA